Brier M.R.,Program in Neuroscience |
Snyder A.Z.,Washington University in St. Louis |
Fagan A.M.,Hope Center for Neurological Disorders |
Fagan A.M.,Knight Alzheimers Disease Research Center |
And 7 more authors.
Neurology | Year: 2014
Objective: To determine whether, and to what degree, preclinical Alzheimer disease (AD) confounds studies of healthy aging where "healthy" is based on cognitive normality alone. Methods: We examined the effects of preclinical AD in cognitively normal older individuals using resting-state functional connectivity MRI. We investigated 2 groups of cognitively normal participants: one group with evidence of preclinical AD as assessed by CSF markers of AD and the other group with normal CSF biomarkers. Results: There were significant interactions between age and biomarker status in the defaultmode, dorsal attention, and salience resting-state networks. In the group with evidence of preclinical AD, there were dramatic changes in functional connectivity with age. In the group without evidence of preclinical AD, those changes were greatly attenuated. In most regions with significant interactions of age and biomarker status, the age-related change in functional connectivity in the normal biomarker group was indistinguishable from zero. Conclusions: These results suggest that preclinical AD accounts for a substantial portion of the reported effects of aging in the extant functional connectivity literature. © 2014 American Academy of Neurology.
Schindler M.K.,University of Pennsylvania |
McQuail J.A.,Program in Neuroscience
PLoS ONE | Year: 2012
Radiation therapy has proven efficacy for treating brain tumors and metastases. Higher doses and larger treatment fields increase the probability of eliminating neoplasms and preventing reoccurrence, but dose and field are limited by damage to normal tissues. Normal tissue injury is greatest during development and in populations of proliferating cells but also occurs in adults and older individuals and in non-proliferative cell populations. To better understand radiation-induced normal tissue injury and how it may be affected by aging, we exposed young adult, middle-aged, and old rats to 10 Gy of whole brain irradiation and assessed in gray- and white matter the responses of microglia, the primary cellular mediators of radiation-induced neuroinflammation, and oligodendrocyte precursor cells, the largest population of proliferating cells in the adult brain. We found that aging and/or irradiation caused only a few microglia to transition to the classically "activated" phenotype, e.g., enlarged cell body, few processes, and markers of phagocytosis, that is seen following more damaging neural insults. Microglial changes in response to aging and irradiation were relatively modest and three markers of reactivity - morphology, proliferation, and expression of the lysosomal marker CD68- were regulated largely independently within individual cells. Proliferation of oligodendrocyte precursors did not appear to be altered during normal aging but increased following irradiation. The impacts of irradiation and aging on both microglia and oligodendrocyte precursors were heterogeneous between white- and gray matter and among regions of gray matter, indicating that there are regional regulators of the neural response to brain irradiation. By several measures, the CA3 region of the hippocampus appeared to be differentially sensitive to effects of aging and irradiation. The changes assessed here likely contribute to injury following inflammatory challenges like brain irradiation and represent important end-points for analysis in studies of therapeutic strategies to protect patients from neural dysfunction. © 2012 Hua et al.
Devineni A.V.,Program in Neuroscience |
Guarnieri D.J.,Yale University |
Corl A.B.,Program in Neuroscience |
Wolf F.W.,University of california |
And 2 more authors.
Fly | Year: 2011
The relationship between alcohol consumption, sensitivity and tolerance is an important question that has been addressed in humans and rodent models. Studies have shown that alcohol consumption and risk of abuse may correlate with (1) increased sensitivity to the stimulant effects of alcohol, (2) decreased sensitivity to the depressant effects of alcohol and (3) increased alcohol tolerance. however, many conflicting results have been observed. To complement these studies, we utilized a different organism and approach to analyze the relationship between ethanol consumption and other ethanol responses. Using a set of 20 Drosophila melanogaster mutants that were isolated for altered ethanol sensitivity, we measured ethanol-induced hyperactivity, ethanol sedation, sedation tolerance and ethanol consumption preference. ethanol preference showed a strong positive correlation with ethanol tolerance, consistent with some rodent and human studies, but not with ethanol hyperactivity or sedation. No pairwise correlations were observed between ethanol hyperactivity, sedation and tolerance. The evolutionary conservation of the relationship between tolerance and ethanol consumption in flies, rodents and humans indicates that there are fundamental biological mechanisms linking specific ethanol responses. © 2011 Landes Bioscience.
Messina G.,San Raffaele Scientific Institute |
Messina G.,University of Milan |
Biressi S.,Stanford University |
Monteverde S.,San Raffaele Scientific Institute |
And 12 more authors.
Cell | Year: 2010
Skeletal myogenesis, like hematopoiesis, occurs in successive developmental stages that involve different cell populations and expression of different genes. We show here that the transcription factor nuclear factor one X (Nfix), whose expression is activated by Pax7 in fetal muscle, in turn activates the transcription of fetal specific genes such as MCK and β-enolase while repressing embryonic genes such as slow myosin. In the case of the MCK promoter, Nfix forms a complex with PKC theta that binds, phosphorylates, and activates MEF2A. Premature expression of Nfix activates fetal and suppresses embryonic genes in embryonic muscle, whereas muscle-specific ablation of Nfix prevents fetal and maintains embryonic gene expression in the fetus. Therefore, Nfix acts as a transcriptional switch from embryonic to fetal myogenesis. © 2010 Elsevier Inc. All rights reserved.
Conner K.R.,Program in Neuroscience |
Forbes M.E.,Medical Center Boulevard |
Lee W.H.,Virginia Polytechnic Institute and State University |
Lee Y.W.,Virginia Polytechnic Institute and State University |
And 2 more authors.
Radiation Research | Year: 2011
Blockers of the renin-angiotensin-aldosterone system (RAAS) ameliorate cognitive deficits and some aspects of brain injury after whole-brain irradiation. We investigated whether treatment with the angiotensin II type 1 receptor antagonist L-158,809 at a dose that protects cognitive function after fractionated whole-brain irradiation reduced radiation-induced neuroinflammation and changes in hippocampal neurogenesis, well-characterized effects that are associated with radiation-induced brain injury. Male F344 rats received L-158,809 before, during and after a single 10-Gy dose of radiation. Expression of cytokines, angiotensin II receptors and angiotensin-converting enzyme 2 was evaluated by real-time PCR 24 h, 1 week and 12 weeks after irradiation. At the latter times, microglial density and proliferating and activated microglia were analyzed in the dentate gyrus of the hippocampus. Cell proliferation and neurogenesis were also quantified in the dentate subgranular zone. L-158,809 treatment modestly increased mRNA expression for Ang II receptors and TNF-α but had no effect on radiation-induced effects on hippocampal microglia or neurogenesis. Thus, although L-158,809 ameliorates cognitive deficits after whole-brain irradiation, the drug did not mitigate the neuroinflammatory microglial response or rescue neurogenesis. Additional studies are required to elucidate other mechanisms of normal tissue injury that may be modulated by RAAS blockers. © 2011 by Radiation Research Society.
Gustina A.S.,Program in Neuroscience |
Gustina A.S.,University of Maryland, Baltimore |
Trudeau M.C.,University of Maryland, Baltimore
Journal of General Physiology | Year: 2011
Human ether-á-go-go-related gene (hERG) potassium channels have voltage-dependent closing (deactivation) kinetics that are unusually slow. A Per-Arnt-Sim (PAS) domain in the cytoplasmic N-terminal region of hERG regulates slow deactivation by making a direct interaction with another part of the hERG channel. The mechanism for slow deactivation is unclear, however, because the other regions of the channel that participate in regulation of deactivation are not known. To identify other functional determinants of slow deactivation, we generated hERG channels with deletions of the cytoplasmic C-terminal regions. We report that hERG channels with deletions of the cyclic nucleotide-binding domain (CNBD) had accelerated deactivation kinetics that were similar to those seen in hERG channels lacking the PAS domain. Channels with dual deletions of the PAS domain and the CNBD did not show further acceleration in deactivation, indicating that the PAS domain and the CNBD regulate deactivation by a convergent mechanism. A recombinant PAS domain that we previously showed could directly regulate PAS domain-deleted channels did not regulate channels with dual deletions of the PAS domain and CNBD, suggesting that the PAS domain did not interact with CNBD-deleted channels. Biochemical protein interaction assays showed that glutathione S-transferase (GST)-PAS (but not GST) bound to a CNBD-containing fusion protein. Coexpression of PAS domain-deleted subunits (with intact C-terminal regions) and CNBD-deleted subunits (with intact N-terminal regions) resulted in channels with partially restored slow deactivation kinetics, suggesting regulatory intersubunit interactions between PAS domains and CNBDs. Together, these data suggest that the mechanism for regulation of slow deactivation in hERG channels is an interaction between the N-terminal PAS domain and the C-terminal CNBD. © 2011 Gustina and Trudeau.
Meighan S.E.,Program in Neuroscience |
Meighan P.C.,Program in Neuroscience |
Rich E.D.,Program in Neuroscience |
Brown R.L.,Washington State University |
Varnum M.D.,Washington State University
Biochemistry | Year: 2013
Cyclic-nucleotide gated (CNG) channels are essential for phototransduction within retinal photoreceptors. We have demonstrated previously that the enzymatic activity of matrix metalloproteinase-2 and-9, members of the matrix metalloproteinase (MMP) family of extracellular, Ca2+-and Zn 2+-dependent proteases, enhances the ligand sensitivity of both rod (CNGA1 and CNGB1) and cone (CNGA3 and CNGB3) CNG channels. Additionally, we have observed a decrease in the maximal CNG channel current (Imax) that begins late during MMP-directed gating changes. Here we demonstrate that CNG channels become nonconductive after prolonged MMP exposure. Concurrent with the loss of conductive channels is the increased relative contribution of channels exhibiting nonmodified gating properties, suggesting the presence of a subpopulation of channels that are protected from MMP-induced gating effects. CNGA subunits are known to possess one extracellular core glycosylation site, located at one of two possible positions within the turret loop near the pore-forming region. Our results indicate that CNGA glycosylation can impede MMP-dependent modification of CNG channels. Furthermore, the relative position of the glycosylation site within the pore turret influences the extent of MMP-dependent proteolysis. Glycosylation at the site found in CNGA3 subunits was found to be protective, while glycosylation at the bovine CNGA1 site was not. Relocating the glycosylation site in CNGA1 to the position found in CNGA3 recapitulated CNGA3-like protection from MMP-dependent processing. Taken together, these data indicate that CNGA glycosylation may protect CNG channels from MMP-dependent proteolysis, consistent with MMP modification of channel function having a requirement for physical access to the extracellular face of the channel. © 2013 American Chemical Society.
News Article | January 14, 2016
The paper, published today in Current Biology, is the first to confirm that a key aspect of human memory impaired in memory disorders exists in the type of pre-clinical animal models that influence major decisions about drug development. The study's results, which required over a year's worth of intensive data collection and analysis, could hold important insights for drug companies. That's because selecting less relevant data early in the research process can create costly errors later in the "translational pipeline" that connects basic science to new treatments and therapies. "There is a huge history of translation failure in memory disorders caused by companies trying to develop compounds based on therapies that produce relief in pre-clinical animal models but later fail during early clinical trials," said Jonathon Crystal, professor in the IU Bloomington College of Arts and Sciences' Department of Psychological and Brain Sciences and director of the Program in Neuroscience, who led the study. "We're working to create stronger pre-clinical models of the types of memory systems that are impaired in human diseases." The conclusions are notable in light of the federal government's recent 60 percent increase in Alzheimer's disease research funding, or $350 million in new spending. No treatment currently exists to halt or reverse the long-term effects of Alzheimer's disease, estimated to affect 5.3 million people in the United States alone. The IU study, conducted in rats, shows for the first time that the animals possess two independent "working memory" resources, or the ability to remember more information across two categories versus a single category. In humans, working memory consists of two memory resources: visual and auditory information. The average person, for example, cannot recall a phone number longer than seven characters despite easily remembering both the audio and video on a television show. To test these forms of memory in animals, Crystal's team challenged rats to memorize odors and spatial information. To test rats' ability to remember spatial data, IU scientists had them find food pellets inside an eight-arm maze. To test their ability to remember new odors, they used pellets inside containers scented by up to 100 common household spices, with only new odors yielding food. Across numerous trials, IU scientists consistently showed that the rats could recall significantly more details in combination—scents and spaces—compared to trying to remember a single type of information. "We saw high-level performance because the animals were encoding information in two dedicated memory resources," Crystal said. "This is the defining quality of working memory in people; and for the first time, we've shown animals have this property of independent memory systems as well." The results also suggest that this form of memory arose evolutionarily much earlier than previously thought. Historically, Crystal said almost all investigations on the genetics of Alzheimer's disease depend upon spatial memory research because these studies are easier to carry out. Yet treatments based solely upon spatial memory data aren't likely to strike at the heart of what's so cruel about memory disorders. It's critical to also investigate more complex forms of memory, including working memory. "What researchers are doing now is akin to coming up with a plan for developing a drug which, if successful after spending billions of dollars, helps your grandmother find her reading glasses or car keys," Crystal said. "Those symptoms aren't the most debilitating aspect of Alzheimer's disease. We need solutions that address the inability to remember significant things, like memories of the past or personal exchanges with friends and family, whose loss is so distressing to sufferers of the disease and their loved ones." The IU study was made possible in part by student researchers from the College of Arts and Sciences whose work helped overcome the significant time investment required to perform complex memory trials in animals. IU students who contributed to the project were first author Alexander Bratch, now a graduate student at the University of Minnesota, who wrote his undergraduate thesis on the work; Diana Arman, Austin Dunn, Shiloh Cooper, Hannah Corbin, Stefan Dalecki and Spencer Kann, all undergraduates, and Alexandra Smith, a graduate student. Explore further: New discovery on animal memory opens doors to research on memory impairment diseases
DiLeonardi A.M.,Program in Neuroscience |
Huh J.W.,Children's Hospital of Philadelphia |
Raghupathi R.,Program in Neuroscience |
Raghupathi R.,Drexel University
Journal of Neuropathology and Experimental Neurology | Year: 2012
Diffuse axonal injury is a major component of traumatic brain injury in children and correlates with long-term cognitive impairment. Traumatic brain injury in adult rodents has been linked to a decrease in compound action potential (CAP) in the corpus callosum, but information on trauma-associated diffuse axonal injury in immature rodents is limited.We investigated the effects of closed head injury on CAP in the corpus callosum of 17-day-old rats. The injury resulted in CAP deficits of both myelinated and unmyelinated fibers in the corpus callosum between 1 and 14 days postinjury (dpi). These deficits were accompanied by intra-axonal dephosphorylation of the 200-kDa neurofilament subunit (NF200) at 1 and 3 dpi, a decrease in total NF200 at 3 dpi and axonal degeneration at 3 and 7 dpi. Although total phosphatase activity decreased at 1 dpi, calcineurin activity was unchanged. The calcineurin inhibitor, FK506, significantly attenuated the injury-induced NF200 dephosphorylation of NF200 at 3 dpi and axonal degeneration at 3 and 7 dpi but did not affect the decrease in NF200 protein levels or impaired axonal transport. FK506 had no effect on CAP deficits at 3 dpi but exacerbated the deficit in only the myelinated fibers at 7 dpi. Thus, in contrast to adult animals, FK506 treatment did not improve axonal function in brain-injured immature animals, suggesting that calcineurin may not contribute to impaired axonal function. Copyright © 2012 by the American Association of Neuropathologists, Inc.
Kulakowski S.A.,Program in Neuroscience |
Parker S.D.,Health Science University |
Personius K.E.,Program in Neuroscience |
Personius K.E.,Health Science University
Journal of Applied Physiology | Year: 2011
Acute blockade of signaling through the tyrosine kinase receptor B (TrkB) attenuates neuromuscular transmission and fragments postsynaptic acetylcholine receptors (AChRs) in adult mice, suggesting that TrkB signaling is a key regulator of neuromuscular function. Using immunohistochemical, histological, and in vitro muscle contractile techniques, we tested the hypothesis that constitutively reduced TrkB expression would disrupt neuromuscular pre- and postsynaptic structure, neurotransmission, muscle fiber size, and muscle function in the soleus muscle of 6- to 8-mo-old TrkB +/ - mice compared with age-matched littermates. Age-like expansion of postsynaptic AChR area, AChR fragmentation, and denervation was observed in TrkB +/ - mice similar to that found in 24-mo-old wild-type mice. Neurotransmission failure was increased in TrkB +/ - mice, suggesting that these morphologic changes were sufficient to alter synaptic function. Reduced TrkB expression resulted in decreased muscle strength and fiber cross-sectional area. Immunohistochemical and muscle retrograde labeling experiments show that motor neuron number and size are unaffected in TrkB +/ - mice. These results suggest that TrkB- signaling at the neuromuscular junction plays a role in synaptic stabilization, neurotransmission, and muscle function and may impact the aging process of sarcopenia. © 2011 the American Physiological Society.